2025 SID Annual Meeting Coverage: Does Estrogen Therapy Confer a Survival Advantage for Melanoma Patients? May 8, 2025
As PDUFA Data Nears, Roflumilast Foam 0.3% (Zoryve, Arcutis) Improves Scalp and Body Pso Symptoms, Including Itch, in Phase 3 Study May 7, 2025
Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD